期刊名称：PHYSIOLOGICAL GENOMICS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Physiological Genomics
Physiological Genomics publishes results of a wide variety of studies from human and from informative model systems with techniques linking genes and pathways to physiology, from prokaryotes to eukaryotes. The Journal encourages the submission of research that links genes to cell replication, development, metabolic function, cell signal transduction and intracellular signaling pathways, tissue and organ function, and whole organism function.
Physiological Genomics encourages the utilization of approaches ranging from expression profiling, assays for molecular interactions, natural and directed gene alteration, selective breeding studies, gene identification, and the assessment of gene/environment interaction. The Journal welcomes important new technologies and concepts that enhance the study of functional genomics. The Journal encourages publication of new computational approaches, integrative models, and image analysis predictive of gene function.
Physiological Genomics also publishes invited reviews and perspectives that enhance the understanding of the link between genetics and physiology. The Journal is committed to rapid peer review to ensure the publication of high-quality papers and timely news and review articles.
Instructions to Authors
General Information
The American Physiological Society (APS) Journals seek definitive papers that present the entire contents of a research project. In general, all data from a group of subjects, animals, or samples should be presented together in a single paper. If this cannot be done, then the manuscript should be cross-referenced. Identical subject, animal, and sample numbers should be used in the different manuscripts to identify their commonality.
Peer Review Policy
Manuscripts are refereed critically by two or more reviewers. Acceptance of manuscripts is based on scientific content and presentation of the material; membership in the Society is not a prerequisite for publication. The Editor/Associate Editor selects the reviewers, corresponds with the author, and makes the final decision on the acceptance or rejection of the manuscript. If a manuscript is submitted by an Editor of the Journal, another Editor handles that manuscript. The APS Peer Review office helps ensure confidentiality by setting up blinded user records in the APS Central system to be used for this purpose. See also Peer Review and Revision.
Copyright and Permissions
The Mandatory Submission Form serves as the official copyright transfer form. The APS Journals are copyrighted for the protection of authors and the Society. The code at the bottom of the first page of an article indicates the copyright owner's consent that copies of that article may be made beyond what is permitted by sections 107 and 108 of the US Copyright Law -- unless the copies are for general distribution, for advertising, for creating new works, or for resale -- provided the per-copy fee is paid through the Copyright Clearance Center, Inc.:
Copyright Clearance Center, Inc.
222 Rosewood Dr.
Danvers, MA 01923
For information about any of these exceptions or for permission to reproduce previously published illustrations or tables, write to:
Publications Office
American Physiological Society
9650 Rockville Pike
Bethesda, MD 20814-3991
Include an explicit statement of intended use and detailed specification of the material to be reproduced.
Cost of Publication
Mandatory Submission Fee
Page Charges
Cost of Color
Among scholarly publishers, the APS offers one of the most favorable terms for color figure publication.
- We publish color figures free of charge if the first or the last author is an APS nonstudent member in good standing.
- The APS student members and nonmembers will be charged the low subsidized rate of $300 per color figure.
- Color is free for authors publishing in Physiological Reviews, Physiological Genomics, and News in Physiological Sciences.
- At proof stage, if the author requests a color Iris proof copy of his/her figure(s), a service charge of $75 per figure will be added to the article publication fees.
Open Access choice for authors of Physiological Genomics
Starting July 1, 2003, authors can choose to pay a $1,500 fee to have their article published online with Open Access from the first date of publication or choose to pay no author fees and leave their article under Subscription Access.
Upon acceptance, you will be asked to download a form, where you will choose author-fee-based Open Access or Subscription Access. If you choose Open Access, you will be asked to provide a credit card number, purchase order, or check for $1,500. Once your payment or purchase order is processed, your online article will be made free to all. The print journal containing your article will still be available for a subscription fee.
Reprint Services
The APS provides high quality reprints to its authors.
- Please order reprints when you receive the electronic or mailed proof of your article.
- The Reprint Order Form is enclosed in the proof package. Please fill it out and send within 48 hours to the address indicated on the form. Please note that the articles containing color can ONLY be ordered at proof stage.
- If your article has color figures, there is an additional press charge of $90 per 100 reprints ordered.
- Toll-free link: at your request, the APS can create a link from your online published article to a URL you specify. Readers accessing your article from this URL can do so without a subscription to the journal. The per-article cost is $150 ($250 for articles in Physiological Reviews) and can be noted on the Reprint Order Form. Payment for the link will be added to the invoice for publication fees.
- See the current reprint prices.
Restrictions on Prepublication
Except in reviews and invited editorials, the APS Journals will not accept submissions in which, other than in abstracts of less than 400 words, a significant portion of the data in the form of figures and/or tables has been published elsewhere. For the APS guidelines regarding duplicate and/or prior publication, see the APS Ethical Policies and Procedures.
Authorship Changes
Changes to authorship are handled differently depending on when the error is noticed, i.e., on the stage of publication of the paper.
1. After submission but before acceptance
If you realize that changes to authorship (e.g., altering the order of authorship or adding/removing a name) are needed, please follow these steps:
o Download the Change of Authorship Form.
o Have ALL authors sign it.
o Fax, mail, or e-mail the signed form to the APS Peer Review office (301-634-7243)
2. After publication in Articles in PresS
If you have realized that an author's name was misspelled in such way as to affect finding the article in PubMed or through other searches, notify the Peer Review office so that the article can be fixed by amending the Article in PresS edition. Please note: this is the ONLY case when Articles in PresS edition will be corrected. Follow the steps above when submitting the correction. Other authorship corrections can still be made for the final print and online editions (see point 3 below).
3. During production of the final print and online editions
Changes to authorship (e.g., altering the order of authorship; adding/removing a name; adding or changing an initial) can still be made during production. You will need to follow these steps:
o Download the Change of Authorship Form.
o Have ALL authors sign it.
o Fax, mail, or e-mail the signed form to the Journal Editorial Office (301-634-7243).
4. After the final edition has been published in print and online
Any changes to authorship can only be made through a corrigendum to the print edition. The online version will have a permanent link to the corrigendum. Follow the steps in point 3 when submitting the changes.
Conflict of Interest
Authors of research articles are required at the time of submission to disclose to the APS Publications Office any potential conflict of interest (e.g., consultancies, stock ownership, equity interests, patent-licensing arrangements, lack of access to data, or lack of control of the decision to publish). In such cases, the author(s) will be asked to fill out a Conflict of Interest Disclosure form. The information provided in the form, unless already disclosed in the submitted article, will be held in confidence while the paper is under review. If the article is accepted for publication, information on the potential conflict of interest -- including a lack of control of the decision to publish -- will be included in the Disclosures section, following the Acknowledgments section.
Use of Previously Published Illustrations
APS Journals do not allow the use of previously published illustrations in regular research papers. If scientifically appropriate, previously published illustrations may be included only in reviews, invited editorials, or other invited papers, and only if permission is obtained from both the author and the original publisher. Authors are responsible for obtaining permission letters and must include them with their accepted manuscript in advance of publication. Authors are also responsible for providing publication-quality electronic files or laser prints of the previously published illustrations. These are best obtained from the original publisher or original author. Previously published images downloaded from the Internet are not acceptable for publication. See also Special Considerations for Invited Authors.
"Submitted" and "Accepted" Dates
The "submitted" date for a manuscript is the date when the manuscript was submitted to APS Central online peer review system. The "accepted" date is the date when the official letter of acceptance is sent out (usually via e-mail) from the review Editor. For specific requirements, see Paper Acceptance.
"Advertisement" Note
The APS is required by US Postal regulations to affix the following note on the title page of all articles for which page charges are assessed: "The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked 'advertisement' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact."
Ethical Policies and Standards
APS Ethical Policy
The journals of the American Physiological Society (APS) only accept research papers that are original work, no part of which has been submitted for publication elsewhere except as brief abstracts. When submitting a paper, the corresponding author should include copies of related manuscripts submitted or in press elsewhere. Taking material from another¡¯s work and submitting it as one¡¯s own is considered plagiarism. Fabricating a report of research or suppressing or altering data to agree with one¡¯s conclusions is considered fraud.
The Editors expect each author to have made an important scientific contribution to the study and be thoroughly familiar with the original data. The Editors also expect each author to have read the complete manuscript and to take responsibility for the content and completeness of the manuscript and to understand that if the paper, or part of the paper, is found to be faulty or fraudulent, that he/she shares responsibility with his/her coauthors. The Mandatory Submission Form, which is published in the journals, should be signed by each author. In cases in which obtaining a signature from each author would delay publication, the corresponding author¡¯s signature is sufficient provided that the corresponding author understands that he or she signs on behalf of the other authors who have not signed the form. An author¡¯s name can be removed only at his/her request, but all coauthors must sign a change of authorship agreement for any change in authorship (additions, removals, or change of order) to be made.
Authors of research articles are required at the time of submission to disclose to the APS Publications Office any potential conflict of interest (e.g., consultancies, stock ownership, equity interests, patent-licensing arrangements) and that they accept full responsibility for the conduct of the trial, had full access to all the data, and controlled the decision to publish. Failure to do so may jeopardize eventual publication. Such potential conflict, unless already disclosed in the submitted article, will be held in confidence while the paper is under review. If the article is accepted for publication, information on the potential conflict of interest will be included in the acknowledgments section of the article.
APS reviewers have a responsibility to report suspected duplicate publication, fraud, or plagiarism to the Editor. A reviewer may recognize and report that he/she is refereeing, or has recently refereed, a similar or identical paper for another journal by the same author(s). Readers may report that they have seen the same article elsewhere, or authors may see their own published work being plagiarized. In all cases the first action of the journal Editor is to inform the Publications Committee Chair through the Director of Publication by supplying copies of 1) the relevant material and 2) a draft letter to the corresponding author asking for an explanation in a nonjudgmental manner. The Publications Committee Chair must approve any correspondence with the author before it is sent to the author. If the author¡¯s explanation is unacceptable and it seems that serious unethical conduct has taken place, the matter is referred to the Publications Committee. After deliberation, a decision is made whether the case is serious enough to warrant a ban on future submissions and/or if the offending author¡¯s institution should be informed. The decision has to be approved by the Executive Cabinet of the APS Council, and the author has the right of appeal, with the opportunity to present his/her position, to the Publications Committee and the full APS Council.
If the infraction is less severe, the Editor, upon the advice of the Publications Chair, sends the author a letter of reprimand and reminds the author of APS publication policies; if the manuscript has been published, the Editor may require the author to publish an apology in the journal to correct the record. If, through the author¡¯s actions, APS has violated the copyright of another journal, the Publications Chair writes a letter of apology to the other journal.
The APS guidelines for duplicate publication are summarized as follows. Material published by the author before submission in the following categories is considered prior publication: 1) articles published in any journal; 2) articles, book chapters, and long abstracts containing original data in figures and tables, especially in proceedings publications; 3) widely circulated, copyrighted, or archival reports, such as the technical reports of IBM, the preliminary reports of MIT, the institute reports of the US Army, or the internal reports of NASA; 4) meeting poster presentations that are videotaped and sold; except as noted below. Data portions of submitted papers that have appeared on an author¡¯s personal web site will be permitted, with the proviso that the author inform the Editor at the time of the submission that such material exists so that the Editor can determine the suitability of such material for publication. Failure to do so will result in an automatic rejection of the manuscript. Examples of such work include, but are not limited to, immunofluorescence micrographs and/or animated gif/video files posted on a personal web site, or NIH-mandated posting of DNA microarray data. After the article is published in a journal of the American Physiological Society, the data should be removed from the author¡¯s web site.
Authors with concerns about possible prior publication that does not fall clearly into one of these categories should contact the Director of Publications and forward the material for examination.
Editorial Board
Editor-in-Chief: Allen W. Cowley, Jr.
Medical College of Wisconsin
e-mail: pgeditor@mcw.edu <pgeditor@mcw.edu>
Consulting Editors
Victor J. Dzau (Founding Editor), Brigham & Women's Hospital
Richard P. Lifton, Yale University School of Medicine
Len I. Zon, Children's Hospital, Boston
Associate Editors
Andrew S. Greene, Medical College of Wisconsin
Steven Gullans, Harvard Institutes of Medicine
Howard Jacob, Medical College of Wisconsin
Paul S. Meltzer, National Human Genome Research Institute
David E. Millhorn, Genome Research Institute, University of Cincinnati
Joseph Nadeau, Case Western Reserve University
Jerry Pelletier, McGill University
M. Ian Phillips, University of South Florida
Richard Pratt, Brigham & Women's Hospital
Francesco Ramirez, Mount Sinai Medical Center
Richard J. Roman, Medical College of Wisconsin
Curt D. Sigmund, University of Iowa College of Medicine
Monika Stoll, Christian-Albrechts Universität Kiel
Editorial Board
Hiroyuki Aburatani, University of Tokyo, Japan
Michael Altherr, Los Alamos National Laboratory, New Mexico
Frank Baas, University of Amsterdam, The Netherlands
Wade Berrettini, University of Pennsylvania
Walter Boron, Yale University School of Medicine
C. A. Richard Boyd, University of Oxford, UK
David Brook, University of Nottingham, UK
Howard Bussey, McGill University, Canada
C. Thomas Caskey, Merck Research Laboratories, West Point, PA
Kenneth R. Chien, UCSD Department of Medicine
George Church, Harvard Medical School
Pierre Corvol, I.N.S.E.R.M., France
Anna Dominiczak, University of Glasgow, U.K.
Stanley Fields, HHMI, University of Washington
Mark Fishman, Massachusetts General Hospital-East, Boston
Jeff Friedman, Rockefeller Institute
Akiyoshi Fukamizu, University of Isukuba, Japan
Detlev Ganten, Max Delbruck Center, Germany
Kenneth W. Gross, Roswell Park Cancer Institute
William Guggino, Johns Hopkins University School of Medicine, Baltimore
John Hall, University of Mississippi Medical Center
Steve Harrap, University of Melbourne, Australia
Joseph R. Haywood, University of Texas Health Science Center, San Antonio
I. Humphery-Smith, Centre for Proteome Research and Gene Product Mapping, Everleigh, Australia
Seigo Izumo, Beth Israel Deaconess Medical Center, Boston
Jose Krieger, University of Sao Paulo, Brazil
Jaroslav Kunes, Academy of Sciences, Prague, Czech Republic
Ted Kurtz, UCSF Medical Center
Eric S. Lander, Whitehead Institute, MIT, Cambridge
Bob Lefkowitz, HHMI, Duke University Medical Center, Durham
Hans Lehrach, Max-Planck-Institute, Berlin, Germany
Henry Lester, California Institute of Technology, Pasadena
Harris Lewin, University of Illinois, Urbana
Michael Lovett, UT Southwestern Medical Center at Dallas
Tim McClintock, University of Kentucky
Hugh McDevitt, Stanford University School of Medicine
Roderick McInnes, Hospital for Sick Children, Toronto
John Mullins, University of Edinburgh, UK
Norma J. Nowak, Roswell Park Cancer Institute
Morton Printz, UCSD School of Medicine, La Jolla
John Rapp, Medical College of Ohio, Toledo
M. Riley, Marine Biological Laboratory, Woods Hole
Andrew Rut, SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK
Linda Samuelson, University of Michigan, Ann Arbor
Joshua Sanes, Washington University School of Medicine, St. Louis
Clifford Saper, Harvard Medical School
Jean Sassard, CNRS, Lyon, France
Solomon Snyder, Johns Hopkins University School of Medicine, Baltimore
Marcelo Bento Soares, University of Iowa
George Stamatoyannopoulos, University of Washington
Kevin Strange, Vanderbilt University School of Medicine
Joe Takahashi, HHMI, Northwestern University, Evanston
Rudolph Tanzi, Massachusetts General Hospital-East, Boston
Susumu Tonegawa, M.I.T., Cambridge
Thomas Unger, University of Kiel, Germany
Hartmut Weiler, Blood Center Research Institute, Milwaukee
Michael J. Welsh, HHMI, University of Iowa
Morris White, HHMI, Joslin Diabetes Center, Boston
Bernard Zabel, University of Mainz, Germany
|
